Page last updated: 2024-09-03

l 158809 and lisinopril

l 158809 has been researched along with lisinopril in 4 studies

Compound Research Comparison

Studies
(l 158809)
Trials
(l 158809)
Recent Studies (post-2010)
(l 158809)
Studies
(lisinopril)
Trials
(lisinopril)
Recent Studies (post-2010) (lisinopril)
137072,210648491

Protein Interaction Comparison

ProteinTaxonomyl 158809 (IC50)lisinopril (IC50)
Angiotensin-converting enzyme Homo sapiens (human)0.0021
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.287
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0012
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.0012

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patchett, AA1
Bertani, T; Colosio, V; Corna, D; Donadelli, R; Facchinetti, D; Luzzana, E; Maffi, R; Remuzzi, G; Testa, D; Zoja, C1
Benigni, A; Gagliardini, E; Grunkemeyer, JA; Kalluri, R; Remuzzi, G; Tomasoni, S; Zoja, C1
Bos, H; De Boer, E; De Jong, PE; De Zeeuw, D; Henning, RH; Navis, G; Tiebosch, AT1

Other Studies

4 other study(ies) available for l 158809 and lisinopril

ArticleYear
Excursions in drug discovery.
    Journal of medicinal chemistry, 1993, Jul-23, Volume: 36, Issue:15

    Topics: Awards and Prizes; Drug Design; Humans; Research; Technology, Pharmaceutical

1993
The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1997, Volume: 29, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chronic Disease; Extracellular Matrix Proteins; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Imidazoles; Kidney; Lisinopril; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Tetrazoles; Transforming Growth Factor beta

1997
Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis.
    Journal of the American Society of Nephrology : JASN, 2001, Volume: 12, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Base Sequence; DNA Primers; Glomerulonephritis; Imidazoles; In Situ Hybridization; Kidney Glomerulus; Lisinopril; Male; Membrane Proteins; Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles

2001
Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
    Kidney international, 2002, Volume: 61, Issue:2

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antineoplastic Agents; Blood Pressure; Body Weight; Disease Models, Animal; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Imidazoles; Lisinopril; Male; Nephrosis; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles

2002
chemdatabank.com